title: Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue.
abstract: BACKGROUND
  Data from human epidemiological studies, cultured mammalian cells, and animal models have supported a potentially beneficial role of selenium (Se) in prostate cancer prevention. In addition, Se-containing proteins including members of the glutathione peroxidase (GPx) family and Selenium-Binding Protein 1 (SBP1) have been linked to either cancer risk or development. For example, SBP1 levels are typically reduced in tumors compared to non-cancerous tissue, with the degree of reduction associated with increasingly poor clinical outcome.
  
  
  METHODS
  In order to investigate inter-relationships between blood and tissue Se levels and GPx activity, tissue SBP1 levels, and disease aggressiveness using the Gleason score, we measured levels of selenium and selected selenoproteins in fasting serum and histologically normal prostate tissues obtained from 24 men undergoing radical prostatectomy for the treatment of localized prostate cancer.
  
  
  RESULTS
  GPx enzyme activity was inversely correlated with SBP1 levels in prostate tissue as determined by densitometry of Western blots obtained using anti-SBP1 antibodies [partial Spearman's correlation coefficients and corresponding P-values overall and in African-Americans = -0.42 (0.08) and -0.53 (0.10), respectively], which is consistent with previous observations in cultured cells and mice. Of particular interest was the positive correlation between tissue GPx activity and Gleason score, with this relationship achieving statistical significance among African-Americans (r = 0.67, P = 0.02).
  
  
  CONCLUSIONS
  These studies support the continued investigation of the role of Se and selenoproteins in prostate cancer prevention, development, and prognosis.
authors.affiliation: Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA.
authors.forename: Anita
authors.initials: A
authors.lastname: Jerome-Morais
authors.forename: Margaret E
authors.initials: ME
authors.lastname: Wright
authors.forename: Rui
authors.initials: R
authors.lastname: Liu
authors.forename: Wancai
authors.initials: W
authors.lastname: Yang
authors.forename: Matthew I
authors.initials: MI
authors.lastname: Jackson
authors.forename: Gerald F
authors.initials: GF
authors.lastname: Combs
authors.forename: Alan M
authors.initials: AM
authors.lastname: Diamond
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood / Q000378:metabolism*; D002454:Cell Differentiation / Q000502:physiology; D004789:Enzyme Activation / Q000502:physiology; D005979:Glutathione Peroxidase / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D011467:Prostate / Q000378:metabolism* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D051137:Selenium-Binding Proteins / Q000097:blood*
chemical_list: D014408:Biomarkers, Tumor; C495175:SELENBP1 protein, human; D051137:Selenium-Binding Proteins; D005979:Glutathione Peroxidase
references.citation: PLoS One. 2009 Nov 16;4(11):e7774
references.pmid: 19924303
references.citation: Prostate. 2009 Nov 1;69(15):1635-42
references.pmid: 19623542
references.citation: Carcinogenesis. 2010 Aug;31(8):1360-6
references.pmid: 20530237
references.citation: J Pathol. 2004 Mar;202(3):321-9
references.pmid: 14991897
references.citation: Am J Clin Nutr. 2009 Jun;89(6):2025S-2039S
references.pmid: 19420095
references.citation: Science. 2003 May 30;300(5624):1439-43
references.pmid: 12775843
references.citation: Cancer Res. 1991 Jan 15;51(2):521-7
references.pmid: 1845955
references.citation: Biol Trace Elem Res. 2007 Mar;115(3):227-42
references.pmid: 17625244
references.citation: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references.pmid: 20610543
references.citation: Proteomics. 2006 Jun;6(11):3466-76
references.pmid: 16645984
references.citation: Cancer Res. 1998 Apr 15;58(8):1750-3
references.pmid: 9563494
references.citation: J Urol. 1974 Jan;111(1):58-64
references.pmid: 4813554
references.citation: Cancer Res. 2002 Nov 15;62(22):6451-5
references.pmid: 12438234
references.citation: Biochim Biophys Acta. 2009 Nov;1790(11):1555-68
references.pmid: 19289149
references.citation: Mol Pharmacol. 2001 Sep;60(3):488-96
references.pmid: 11502879
references.citation: Int J Cancer. 2006 May 15;118(10):2433-40
references.pmid: 16380993
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907
references.pmid: 20647400
references.citation: Cell. 1993 Oct 22;75(2):241-51
references.pmid: 7503812
references.citation: Cancer Res. 2009 Oct 15;69(20):8183-90
references.pmid: 19826042
references.citation: Cancer Res. 1997 Apr 15;57(8):1468-74
references.pmid: 9108447
references.citation: JAMA. 2009 Jan 7;301(1):39-51
references.pmid: 19066370
references.citation: J Biol Chem. 2002 Nov 8;277(45):42867-74
references.pmid: 12221075
references.citation: Mol Nutr Food Res. 2008 Nov;52(11):1289-99
references.pmid: 18435490
references.citation: Carcinogenesis. 1989 Mar;10(3):541-6
references.pmid: 2924398
references.citation: Biochim Biophys Acta. 2009 Nov;1790(11):1546-54
references.pmid: 19289153